A common drug may be able to cure a common illness. Around one in four people have developed long-haul symptoms of COVID-19, ...

With no approved pediatric treatments, Lin wonders whether Serena will be able to attend college. As a community representative for the U.S. National Institutes of Health’s long COVID clinical trials ...

A non-NIH clinical trial is now testing ivermectin, the antiparasitic drug that became a lightning rod during the COVID-19 pandemic, as a potential weapon against one of the most aggressive forms of ...

A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in health workers and others closely exposed to ...

We are living in an epidemic of chronic disease, with a growing number of pesticides, chemicals and food additives implicated in the declining health of Americans. Since 2019, another factor has been ...

A Florida Republican has filed a bill to make a controversial anti-parasitic drug touted as a miracle COVID-19 cure easily available as a human medication. Rep. Jeff Holcomb, R-Spring Hill, on Sept.

Q. My husband got COVID-19 last fall. He has had great success with Paxlovid in the past, when he got it for free during the pandemic. This time, he was charged $800 on his Medicare Drug Plan. That ...

With the COVID pandemic approaching the end of its fifth year, the ninth major wave of infections is washing across the global population infecting tens of millions of people each day. The return to ...

After hinting COVID-19 drug Pemgarda might not work against new strains, the FDA announced the medication is effective against KP.3.1.1, the dominant variant. In August, the FDA said early data ...

Amidst a resurgence of COVID-19 cases across the United States, pharmaceutical company Gilead Sciences, Inc. has announced a voluntary recall of its antiviral drug Veklury, commonly known as ...

Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of symptoms, results of the randomized controlled ACTIV-6 trial showed. After receiving ...

Yep, just in time for Valentine's Day.